Products & Services

FUNDAMIX® Vibro-Mixer

Why conventional agitators struggle with sensitive pharma products Stirred tanks are the default choice in many pharmaceutical plants, but rotating impellers …
FUNDAMIX® Packaged Units and Skids

When a mixer alone is not enough In pharmaceutical production, mixing is rarely an isolated step. Formulation and buffer preparation usually …
FUNDAMIX® SU Single-Use Mixer

Why mixing is a weak point in single-use systems Most single-use mixers still rely on a rotating impeller inside the bag. …
STERIBAC Hygienic Design Candle Filter

Why solid-liquid separation is difficult under GMP In API, antibiotic and vaccine production, separating solids from a liquid often means opening …
FUNDALOOP® SU Single-Use Filter

Why cell harvest is a bottleneck in single-use processing Harvest and clarification are often the least flexible steps in a single-use …

Regulatory Support

Navigating an increasingly complex global regulatory environment is one of the most demanding aspects of bringing a pharmaceutical product to …
Neuroscience Drug Discovery and Disease Modelling

Neurological drug development often fails because early models do not reproduce the human biology that drives disease or measure outcomes …
NHP Biological Products for Translational Research

Non-human primate biological materials are used in research because of their physiological, immunological and genetic similarities to humans. They can …
Vaccine Discovery and Preclinical Development

Vaccine development requires alignment between antigen design, delivery platform, formulation and the immune response needed for protection or therapeutic activity. …
Immuno-Oncology and Engineered Cell Therapy Development

The development of effective cancer immunotherapies requires a clear understanding of tumour biology, immune-cell function and the mechanisms that limit …
Advanced 3D Biology Models for Drug Discovery

Conventional monolayer cultures remain useful for many assays, but they cannot fully reproduce the spatial organisation, cellular diversity and local …
Stem Cell and iPSC Research Solutions

Stem cell models offer a renewable and biologically relevant source of human cells for studying disease mechanisms, evaluating drug candidates …
Gene Therapy Vector and Delivery Development

A gene therapy programme depends on more than the therapeutic sequence alone. Vector architecture, tissue tropism, expression control, delivery efficiency …
Therapeutic Glycoprotein Development and Glycoengineering

Glycosylation can influence the folding, stability, solubility, receptor interactions, serum persistence and immune effector functions of a therapeutic protein. It …
mRNA Therapeutics and LNP Delivery Development

The performance of an mRNA therapeutic depends on both the RNA molecule and the delivery system. Sequence architecture affects stability …